211 related articles for article (PubMed ID: 30341887)
1. Glutathione S-Transferase Gene Polymorphisms are Associated with an Improved Treatment Response to Cisplatin-Based Chemotherapy in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis.
Wang H; Gao X; Zhang X; Gong W; Peng Z; Wang B; Wang L; Chang S; Ma P; Wang S
Med Sci Monit; 2018 Oct; 24():7482-7492. PubMed ID: 30341887
[TBL] [Abstract][Full Text] [Related]
2. Role of GSTM1, GSTT1, and GSTP1 IIe105Val gene polymorphisms in the response to chemotherapy and overall survival of advanced non-small cell lung cancer.
Jia W; Sun JY; Jia KY; Liu XC
Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706763
[TBL] [Abstract][Full Text] [Related]
3. The association between the GSTP1 A313G and GSTM1 null/present polymorphisms and the treatment response of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients: a meta-analysis.
Yang Y; Xian L
Tumour Biol; 2014 Jul; 35(7):6791-9. PubMed ID: 24729086
[TBL] [Abstract][Full Text] [Related]
4. Association of GSTs gene polymorphisms with treatment outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Wu G; Jiang B; Liu X; Shen Y; Yang S
Int J Clin Exp Pathol; 2015; 8(10):13346-52. PubMed ID: 26722539
[TBL] [Abstract][Full Text] [Related]
5. GSTP1, GSTM1, and GSTT1 polymorphisms as predictors of response to chemotherapy in patients with breast cancer: a meta-analysis.
Kong X; Li Z; Li X
Cancer Chemother Pharmacol; 2016 Dec; 78(6):1163-1173. PubMed ID: 27785604
[TBL] [Abstract][Full Text] [Related]
6. Association of GSTP1 and XRCC1 gene polymorphisms with clinical outcome of advanced non-small cell lung cancer patients with cisplatin-based chemotherapy.
Han B; Guo Z; Ma Y; Kang S; Wang Y; Wei Q; Wu X
Int J Clin Exp Pathol; 2015; 8(4):4113-9. PubMed ID: 26097600
[TBL] [Abstract][Full Text] [Related]
7. Association of glutathione S-transferase (GST) genetic polymorphisms with treatment outcome of cisplatin-based chemotherapy for advanced non-small cell lung cancer in a Chinese population.
Xiao HL; Yang ZT; Han F; Wei HX
Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173276
[TBL] [Abstract][Full Text] [Related]
8. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
Miao LF; Ye XH; He XF
PLoS One; 2020; 15(3):e0216147. PubMed ID: 32155154
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism of lysyl oxidase, glutathione S-transferase M1, glutathione-S-transferase T1, and glutathione S-transferase P1 genes as risk factors for lung cancer in Egyptian patients.
El-Deek SEM; Abdel-Ghany SM; Hana RS; Mohamed AAR; El-Melegy NT; Sayed AA
Mol Biol Rep; 2021 May; 48(5):4221-4232. PubMed ID: 34052967
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis in association with GST gene polymorphism and Treatment outcomes of Gemcitabine and Cisplatin/Carboplatin-based chemotherapy among patients with Gallbladder Carcinoma.
Feroz Z; Kumar R; Tiwari S; Kumar M
J Cancer Res Ther; 2024 Jan; 20(1):289-296. PubMed ID: 38554336
[TBL] [Abstract][Full Text] [Related]
11. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on lung cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
Zhang WP; Yang C; Xu LJ; Wang W; Song L; He XF
Medicine (Baltimore); 2021 Jul; 100(26):e26104. PubMed ID: 34190143
[TBL] [Abstract][Full Text] [Related]
12. Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer.
Yuan ZJ; Zhou WW; Liu W; Wu BP; Zhao J; Wu W; He Y; Yang S; Su J; Luo Y
Asian Pac J Cancer Prev; 2015; 16(10):4347-51. PubMed ID: 26028097
[TBL] [Abstract][Full Text] [Related]
13. Associations Among Glutathione S-Transferase T1, M1, and P1 Polymorphisms and the Risk of Oral Leukoplakia.
He P; Wei M; Wang Y; Liu Q
Genet Test Mol Biomarkers; 2016 Jun; 20(6):312-21. PubMed ID: 27152506
[TBL] [Abstract][Full Text] [Related]
14. GSTT1 and GSTP1 polymorphisms and breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 May; 121(1):195-202. PubMed ID: 19760040
[TBL] [Abstract][Full Text] [Related]
15. Glutathione S-transferase polymorphisms (GSTM1, GSTT1 and GSTP1) and their susceptibility to renal cell carcinoma: an evidence-based meta-analysis.
Yang X; Long S; Deng J; Deng T; Gong Z; Hao P
PLoS One; 2013; 8(5):e63827. PubMed ID: 23717494
[TBL] [Abstract][Full Text] [Related]
16. Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population.
Chen JB; Wang F; Wu JJ; Cai M
Genet Mol Res; 2016 Jul; 15(3):. PubMed ID: 27525853
[TBL] [Abstract][Full Text] [Related]
17. Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.
Ye H; Shao M; Shi X; Wu L; Xu B; Qu Q; Qu J
Sci Rep; 2017 Jun; 7(1):2670. PubMed ID: 28572675
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of GSTM1, GSTT1, and GSTP1 with prostate cancer risk: a meta-analysis of 57 studies.
Gong M; Dong W; Shi Z; Xu Y; Ni W; An R
PLoS One; 2012; 7(11):e50587. PubMed ID: 23189206
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in GSTM1, GSTT1 and GSTP1 genes and risk of lung cancer in a North Indian population.
Sharma N; Singh A; Singh N; Behera D; Sharma S
Cancer Epidemiol; 2015 Dec; 39(6):947-55. PubMed ID: 26529288
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-S-transferase M1, M3, T1 and P1 polymorphisms and susceptibility to non-small-cell lung cancer subtypes and hamartomas.
Risch A; Wikman H; Thiel S; Schmezer P; Edler L; Drings P; Dienemann H; Kayser K; Schulz V; Spiegelhalder B; Bartsch H
Pharmacogenetics; 2001 Dec; 11(9):757-64. PubMed ID: 11740339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
